Hostname: page-component-76fb5796d-dfsvx Total loading time: 0 Render date: 2024-04-25T12:52:21.241Z Has data issue: false hasContentIssue false
  • English
  • Français

Oral Contraceptives and Psychiatric Disturbance: Evidence from Research

Published online by Cambridge University Press:  29 January 2018

Myrna M. Weissman  and
Andrew E. Slaby
Myrna M. Weissman*
Affiliation:
Yale University School of Medicine, 100 Park Street, New Haven, Connecticut 06511, U.S.A; Connecticut Mental Health Center
Andrew E. Slaby
Affiliation:
Yale University Department of Psychiatry; Laboratory of Clinical Psychopharmacology, National Institute of Mental Health, Rockville, Maryland 20852, U.S.A.
*
Address requests for reprints to Mrs. Weissman at Yale University School of Medicine
Get access Rights & Permissions [Opens in a new window]

Extract

There is a commonly held conviction among physicians and the lay public that oral contraceptive agents are associated with a high incidence of adverse psychological effects, particularly depressive symptoms. This belief is enhanced by a body of literature which includes case reports, studies of small samples, and overall side effect incidence rates (1–22). Careful, adequately controlled, objective studies of emotional reactions are, however, lacking, and this can be ascribed to the serious problems inherent in the design of such studies. For example, adequate control groups are difficult to establish, and contraceptives cannot easily be randomly assigned. Studies using a placebo must also introduce other contraceptives; nonrandom processes operate in the selection of women for study. Suggestibility secondary to use of medication requires placebo double-blind studies in order to differentiate the psychological from the pharmacological effects.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 123 , Issue 576 , November 1973 , pp. 513 - 518
Copyright
Copyright © Royal College of Psychiatrists, 1973 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

∗

This research was funded in part by Grant #MH 13738 from the National Institutes of Health, Public Health Service, Department of Health, Education and Welfare, Washington, D.C.

A synopsis of this paper was published in the March 1973 Journal.

∗

Andrew K. Slaby, M.S., M.D., was at Yale University, Department of Psychiatry when this study was completed. He was supported by an epidemiology research training grant, #TO-1-6M-0005, Department of Health, Education and Welfare. He currently is a Clinical Associate in the Laboratory of Clinical Psychopharmacology, National Institute of Mental Health, Rockville, Maryland, 20852, U.S.A.

References

1 Gulbero, J., Gelli, M. G., and JoNssoN, C. O. (1969). ‘Mental and sexual adjustment before and after six months use of an oral contraceptive.’ Acta psychiat. Scand., 45, 259–276.Google Scholar
2 Daly, R. J. et al. (1967). ‘Psychosis associated with the use of a sequential oral contraceptive.’ Lancet, ii, 444–445 Google Scholar
3 Glick, I. D. (1967). ‘Mood and behavioural changes associated with the use of the oral contraceptive agents: a review of the literature.’ Psychopharmacologia, 10, 363–374 Google Scholar
4 Goldzieher, J. W., Moses, L., Averkin, E. et al. (1971). ‘Nervousness and depression attributed to oral contraceptives: a double-blind placebo controlled study.’ Am. J. Obstet. Gyn., 111, 1013–1020.Google Scholar
5 Goldzieher, J. W., Moses, L., Averkin, E. et al. (1971). ‘Placebo-controlled double blind crossover investigation of the side effects attributed to oral contraceptives.’ Fertility and Sterility, 22, 609–623.Google Scholar
6 Grant, E. C. E. (1970). ‘Metabolic effects of oral contraceptives.’ Brit. med. J., iii, 402–403.Google Scholar
7 Grant, E. C. E. and Pryse-Davœs, J. (1968). ‘Effect of oral contraceptives on endometrial monoamine oxidase and phosphates.’ Brit. med. J., iii, 777–780.Google Scholar
8 Grounds, D., Davies, B., and Mowbray, R. (1970). ‘The contraceptive pill, side effects and personality: report of a controlled double blind trial.’ Brit. J. Psychiat., 116, 169–172.CrossRefGoogle ScholarPubMed
9 Herzberg, B., and Coppen, A. (1970). ‘Changes in psychological symptoms in women taking oral contraceptives.’ Brit. J. Psychiat., 116, 164.Google Scholar
10 Herzberg, B., Draper, K., Johnson, A. et al. (1971). ‘Oral contraceptives, depression, and libido.’ Brit. med. J., iii, 495–500 Google Scholar
11 Kane, F., Daly, R., Ewino, J. et al. (1967). ‘Mood and behavioral changes with progestational agents.’ Brit. J. Psychiat., 113, 265–268.Google Scholar
12 Kaye, B. (1963). ‘Oral contraceptives and depression.’ J.A.M.A., 186, 522.Google Scholar
13 Klaiber, E. L., Broverman, D. M., Vogel, W., Kobayaski, Y., and Moriarity, D. (1972). ‘Effects of estrogen therapy on plasma M.A.O. activity and E.E.G. driving responses of depressed women.’ Amer. J. Psychiat., 128, 1492–1498.Google Scholar
14 Lester, D. (1969). ‘The antisuicide pill.’ J.A.M.A., 208, 1908.Google Scholar
15 Lewis, Anne, and Hoghughi, M. (1969). ‘An evaluation of depression as a side effect of oral contraceptives.’ Brit. J. Psychiat., 115, 698–701.Google Scholar
16 Marcotte, D. B., Kane, F. J., Obrist, P., and LIPTON, M. A. (1970). ‘Psychophysiologic changes accompanying oral contraceptive use.’ Brit. J. Psychiat., 116, 165–167.Google Scholar
17 Moos, R. H. (1968). ‘Psychological aspects of oral contraceptives.’ Arch. gen. Psychiat., 19, 87–94.Google Scholar
18 Morris, N. M., and Udry, J. R. (1969). ‘Depression of physical activity by contraceptive pills.’ Amer. J. Obstet. Gyn., 104, 1012–1014.Google Scholar
19 Nilsson, A., Jacobson, L., and Ingemanson, C. A. (1967). ‘Side-effects of an oral contraceptive with particular attention to mental symptoms and sexual adaptation.’ Acta obstet, gynaec. Scand., 46, 537–556.Google Scholar
20 Nilsson, L., and Solvell, L. (1967). ‘Clinical studies on oral contraceptives—a randomized, double-blind, crossover study of 4 different preparations (Anovlar Mite, Lyndial MMite, Ovulen and Volidan).’ Acta obstet, gynaec. Scand., 46, Suppl. 8, 1–31.Google Scholar
21 Ostbroaard, E. (1969). ‘Oral anticonception, side effects and risks.’ Acta obstet, gynaec. Scand., 48, Suppl. 1, 57–72.Google Scholar
22 Wiseman, A. (1968). ‘Clinical management of complaints associated with the use of oral contraception.’ Clin. Obstet. Gynec, 11, 716–733.Google Scholar
23 Kutner, S. J. and Brown, W. L. (1972). ‘Types of oral contraceptives, depression and premenstrual symptoms’. J. Nerv. Ment. Dis., 155: 153–162.Google Scholar
24 Kutner, S. J. and Brown, W. L. (1972). ‘History of depression as a risk factor for depression with oral contraceptives and discontinuance.’ J. Nerv. Ment. Dis., 155: 163–169.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.